Role of TGF-β PGE2 in T cell responses during Plasmodium yoelli infection

European Journal of Immunology

Volumn 37, Issue 6, 2007, Pages 1562-1574

  Ocaña Morgner, Carlos ^a   Wong, Kurt A ^a   Lega, Flavia ^a   Dotor, Javier ^b   Borras Cuesta, Francisco ^b   Rodriguez, Ana ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

CD8+ T cells; Malaria; PGE2; Plasmodium yoelli; TGF

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 10; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; LIVER PROTECTION; MALARIA; MOUSE; NONHUMAN; PARASITE IMMUNITY; PLASMODIUM YOELII; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN FUNCTION; SPLEEN; SPOROZOITE;

16,16-DIMETHYLPROSTAGLANDIN E2; ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11C; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DINOPROSTONE; ERYTHROCYTES; INTERLEUKIN-10; MALARIA; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; PLASMODIUM YOELII; RECEPTORS, CHEMOKINE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SPLEEN; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; VACCINATION;

EID: 34250658895     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737068     Document Type: Article

References (76)

1. Marsh, K., Malaria-a neglected disease? Parasitology 1992. 104 Suppl: S53-69.
2. Theander, T. G., Bygbjerg, I. C., Jacobsen, L., Jepsen, S., Larsen, P. B. and Kharazmi, A., Low parasite specific T cell response in clinically immune individuals with low grade Plasmodium falciparum parasitaemia. Trans. R. Soc. Trop. Med. Hyg. 1986. 80: 1000-1001.
3. Cook, I. F., Herpes zoster in children following malaria. J. Trop. Med. Hyg. 1985. 88: 261-264.
4. Mabey, D. C., Brown, A. and Greenwood, B. M., Plasmodium falciparum malaria and Salmonella infections in Gambian children. J. Infect. Dis. 1987. 155: 1319-1321.
5. Whittle, H. C., Brown, J., Marsh, K., Greenwood, B. M., Seidelin, P., Tighe, H. and Wedderburn, L., T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 1984. 312: 449-450.
6. Greenwood, B. M., Bradley-Moore, A. M., Bryceson, A. D. and Palit, A., Immunosuppression in children with malaria. Lancet 1972. 1: 169-172.
7. Williamson, W. A. and Greenwood, B. M., Impairment of the immune response to vaccination after acute malaria. Lancet 1978. 1: 1328-1329.
8. Li, C., Seixas, E. and Langhorne, J., Rodent malarias: the mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite. Med. Microbiol. Immunol. (Berl) 2001. 189: 115-126.
9. Xu, H., Wipasa, J., Yan, H., Zeng, M., Makobongo, M. O., Finkelman, F. D., Kelso, A. and Good, M. F., The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection. J. Exp. Med. 2002. 195: 881-892.
10. Srour, E. F., Segre, M. and Segre, D., Impairment of T-helper function by a Plasmodium berghei-derived immunosuppressive factor. J. Protozool. 1988. 35: 441-446.
11. Khansari, N., Segre, M. and Segre, D., Immunosuppression in murine malaria: a soluble immunosuppressive factor derived from Plasmodium berghei-infected blood. J. Immunol. 1981. 127: 1889-1893.
12. Wilson, N. S., Behrens, G. M., Lundie, R. J., Smith, C. M., Waithman, J., Young, L., Forehan, S. P. et al., Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 2006. 7: 165-172.
13. Elliott, S. R., Kuns, R. D. and Good, M. F., Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria. Infect. Immun. 2005. 73: 2478-2485.
14. Pombo, D. J., Lawrence, G., Hirunpetcharat, C., Rzepczyk, C., Bryden, M., Cloonan, N., Anderson, K. et al., Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 2002. 360: 610-617.
15. Aidoo, M. and Udhayakumar, V., Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development. Parasitol. Today 2000. 16: 50-56.
16. Plebanski, M., Aidoo, M., Whittle, H. C. and Hill, A. V., Precursor frequency analysis of cytotoxic T lymphocytes to pre- erythrocytic antigens of Plasmodium falciparum in West Africa. J. Immunol. 1997. 158: 2849-2855.
17. Clyde, D. F., Most, H., McCarthy, V. C. and Vanderberg, J. P., Immunization of man against sporozite-induced falciparum malaria. Am. J. Med. Sci. 1973. 266: 169-177.
18. Nussenzweig, R. S., Vanderberg, J., Most, H. and Orton, C., Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967. 216: 160-162.
19. Good, M. F. and Doolan, D. L., Immune effector mechanisms in malaria. Curr. Opin. Immunol. 1999. 11: 412-419.
20. Ocaña-Morgner, C., Mota, M. and Rodriguez, A., Malaria blood-stage suppression of liver-stage immunity by dendritic cells. J. Exp. Med. 2003. 197: 143-151.
21. Belnoue, E., Costa, F. T., Frankenberg, T., Vigario, A. M., Voza, T., Leroy, N., Rodrigues, M. M. et al., Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 2004. 172: 2487-2495.
22. Orjih, A. U., Cochrane, A. H. and Nussenzweig, R. S., Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei. Trans. R. Soc. Trop. Med. Hyg. 1982. 76: 57-61.
23. Wang, R., Arevalo-Herrera, M., Gardner, M. J., Bonelo, A., Carlton, J. M., Gomez, A., Vera, O. et al., Immune responses to Plasmodium vivax pre-erythrocytic stage antigens in naturally exposed Duffy-negative humans: a potential model for identification of liver-stage antigens. Eur. J. Immunol. 2005. 35: 1859-1868.
24. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. and Amigorena, S., Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002. 20: 621-667.
25. Ing, R., Segura, M., Thawani, N., Tam, M. and Stevenson, M. M., Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation. J. Immunol. 2006. 176: 441-450.
26. Perry, J. A., Olver, C. S., Burnett, R. C. and Avery, & C., Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J. Immunol. 2005. 174: 5921-5925.
27. + T cell cycle arrest during priming as a consequence of dendritic cell interaction with Plasmodium-infected red cells. J. Immunol. 2005. 175: 3525-3533.
28. Urban, B. C., Willcox, N. and Roberts, D. J., A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA 2001. 98: 8750-8755.
29. Millington, O. R., Di Lorenzo, C., Phillips, R. S., Garside, P. and Brewer, J. M., Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J. Biol. 2006. 5: 5.
30. Stevenson, M. M. and Riley, E. M., Innate immunity to malaria. Nat. Rev. Immunol. 2004. 4: 169-180.
31. Li, C., Sanni, L. A., Omer, F., Riley, E. and Langhorne, J., Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies. Infect. Immun. 2003. 71: 4850-4856.
32. Omer, F. M., de Souza, J. B., Corran, P. H., Sultan, A. A. and Riley, E. M., Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule. J. Exp. Med. 2003. 198: 1817-1827.
33. Omer, F. M. and Riley, E. M., Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J. Exp. Med. 1998. 188: 39-48.
34. Dodoo, D., Omer, F. M., Todd, J., Akanmori, B. D., Koram, K. A. and Riley, E. M., Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J. Infect. Dis. 2002. 185: 971-979.
35. Tsutsui, N. and Kamiyama, T., Transforming growth factor beta-induced failure of resistance to infection with blood-stage Plasmodium chabaudi in mice. Infect. Immun. 1999. 67: 2306-2311.
36. Harris, S. G., Padilla, J., Koumas, L., Ray, D. and Phipps, R. P., Prostaglandins as modulators of immunity. Trends Immunol. 2002. 23: 144-150.
37. Kilunga Kubata, B., Eguchi, N., Urade, Y., Yamashita, K., Mitamura, T., Tai, K., Hayaishi, O. and Horii, T., Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. J. Exp. Med. 1998. 188: 1197-1202.
38. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001. 19: 683-765.
39. Hetttihewa, L. M., Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule. Int. Immunopharmacol. 2003. 3: 1401-1411.
40. Urban, B. C., Ferguson, D. J., Pain, A,, Willcox, N., Plebanski, M., Austyn, J. M. and Roberts, D. J., Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 1999. 400: 73-77.
41. Perry, J. A., Rush, A., Wilson, R. J., Olver, C. S. and Avery, A. C., Dendritic cells from malaria-infected mice are fully functional APC. J. Immunol. 2004. 172: 475-482.
42. Luyendyk, J., Olivas, O. R., Ginger, L. A. and Avery, A. C., Antigen-presenting cell function during Plasmodium yoelii infection. Infect. Immun. 2002. 70: 2941-2949.
43. Massague, J., Cheifetz, S., Boyd, F. T. and Andres, J. L., TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties. Ann. NY Acad. Sci. 1990. 593: 59-72.
44. Engwerda, C. R., Beattie, L. and Amante, F. H., The importance of the spleen in malaria. Trends Parasitol. 2005. 21: 75-80.
45. Zirvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T. and Storkus, W. J., Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 1996. 183: 87-97.
46. Sallusto, F. and Lanzavecchia, A., Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 2000. 177: 134-140.
47. Lee, S. W., Park, Y., Yoo, J. K., Choi, S. Y. and Sung, Y. C., Inhibition of TCR-induced CD8 T cell death by IL-12: regulation of Fas ligand and cellular FLIP expression and caspase activation by IL-12. J. Immunol. 2003. 170: 2456-2460.
48. Riley, E. M., MacLennan, C., Wiatkowski, D. K. and Greenwood, B. M., Suppression of in-vitro lymphoproliferative responses in acute malaria patients can he partially reversed by indomethacin. Parasite Immunol. 1989. 11: 509-517.
49. Ezquerro, I. J., Lasarte, J. J., Dotor, J., Castilla-Cortazar, I., Bustos, M., Penuelas, I., Blanco, G. et al., A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine 2003. 22: 12-20.
50. Bjorkman, D. J., The effect of aspirin and nonsteroidal anti-inflammatory drugs on prostaglandins. Am. J. Med. 1998. 105: 8S-12S.
51. Coleman, R, A., Smith, W. L. and Narumiya, S., International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 1994. 46: 205-229.
52. Bruna-Romero, O., Hafalla, J. C., Gonzalez-Aseguinolaza, G., Sano, G. Tsuji, M. and Zavala, F., Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive realtime PCR. Int. J. Parasitol. 2001. 31: 1499-1502.
53. Fryauff, D. J., Richards, A. L., Baird, J. K., Richie, T. L., Mouzin, E., Tjitra, E., Sutamihardja, M. A. et al., Lymphocyte proliferative response and subset profiles during extended periods of chloroquine or primaquine prophylaxis. Antimicrobial Agents Chemother. 1996. 40: 2737-2742.
54. Otoo, L. N., Riley, E. M., Menon, A., Byass, P. and Greenwood, B. M., Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis. Trans. R. Soc. Trop. Med. Hyg. 1989. 83: 778-782.
55. + T cell response. Immunity 2006. 25: 19-29.
56. Kriegel, M. A., Li, M. O., Sanjabi, S., Wan, Y. Y. and Flavell, R. A., Transforming growth factor-beta: recent advances on its role in immune tolerance. Curr. Rheumatol. Rep. 2006. 8: 138-144.
57. Williams, M. A. and Bevan, M. J., Effector and memory CTL differentiation. Annu. Rev. Immunol. 2007. 25: 171-192.
58. Sponaas, A. M., Cadman, E. T., Voisine, C., Harrison, V., Boonstra, A., O'Garra, A. and Langhorne, J., Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells. J. Exp. Med. 2006. 203: 1427-1433.
59. - Tcells to acquire regulatory cell function. Blood 2003. 101: 5076-5083.
60. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 2005. 23: 287-296.
61. + T cell responses. J. Exp. Med. 2003. 198: 889-901.
62. + regulatory T cells. Nat. Med. 2004. 10: 29-30.
63. Rodriguez-Barbero, A., Dorado, F., Velasco, S., Pandiella, A., Banas, B. and Lopez-Novoa, J. M., TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells. Kidney Int. 2006. 70: 901-909.
64. Wu, Z., Hayashi, Y., Zhang, J. and Nakanishi, H., Involvement of prostaglandin E2 released from leptomeningeal cells in increased expression of transforming growth factor-beta in glial cells and cortical neurons during systemic inflammation. J. Neurosci. Res. 2007. 85: 184-192.
65. Ramirez-Yanez, G. O., Hamlet, S., Jonarta, A., Seymour, G. J. and Symons, A. L., Prostaglandin E2 enhances transforming growth factor-beta 1 and TGF-beta receptors synthesis: an in vivo and in vitro study. Prostaglandins Leukot. Essent. Fatty Acids 2006. 74: 183-192.
66. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. and Flavell, R. A., Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006. 24: 99-146.
67. Gorelik, L. and Flavell, R. A., Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2002. 2: 46-53.
68. Pockaj, B. A., Basu, G. D., Pathangey, L. B., Gray, R. J., Hernandez, J. L., Gendler, S. J. and Mukherjee, P., Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann. Surg. Oncol. 2004. 11: 328-339.
69. Perkins, D. J., Hittiner, J. B., Mwaikambo, E. D., Granger, D. L., Weinberg, J. B. and Anstey, N. M., Impaired systemic production of prostaglandin E2 in children with cerebral malaria. J. Infect. Dis. 2005. 191: 1548-1557.
70. Perkins, D. J., Kremsner, P. G. and Weinberg, J. B., Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria. J. Infect. Dis. 2001. 183: 113-118.
71. Carlton, J. M., Angiuoli, S. V., Suh, B. B., Kooij, T. W., Pertea, M., Silva, J. C., Ermolaeva, M. D. et al., Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 2002. 419: 512-519.
72. Bruna-Romero, O. and Rodriguez, A., Dendritic cells can initiate protective immune responses against malaria. Infect. Immun. 2001. 69: 5173-5176.
73. + cytolyric T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 1991. 3: 579-585.
74. Grillot, D., Michel, M., Muller, I., Tougne, C., Renia, L., Mazier, D., Corradin, G. et al., Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii. Eur. J. Immunol. 1990. 20: 1215-1222.
75. + T cells using an ELISPOT assay. J. Immunol. Methods 1995, 181: 45-54.
76. + T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. Exp. Parasitol. 1996. 84: 223-230.